Immunological reconstitution by allogeneic bone marrow transplantation in a child with the X-linked hyper-IgM syndrome

S. Kawai, Y. Sasahara, M. Minegishi, S. Tsuchiya, H. Fujie, Y. Ohashi, S. Kumaki, T. Konno

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

A successful transplantation of sibling marrow in a patient with the X- linked hyper-IgM syndrome is reported. Engraftment of HLA-identical marrow cells was obtained, although complicated by grade I acute graft-versus-host disease. Expression of the CD40 ligand (CD40L, CD154) by activated T-cells from the recipient remained at low levels until 10 months after the transplantation, but then normalized. The patient is now fully competent in immune function without any episodes of severe infection 24 months later. Conclusion Allogeneic bone marrow transplantation is a reasonable therapeutic option for X-linked hyper-IgM syndrome if HLA-matched family donors are available. Whether dysregulation of CD40L expression causes post-transplant immunological abnormalities remains to be clarified.

Original languageEnglish
Pages (from-to)394-397
Number of pages4
JournalEuropean Journal of Pediatrics
Volume158
Issue number5
DOIs
Publication statusPublished - 1999

Keywords

  • Bone marrow transplantation
  • CD40 ligand (CD154)
  • X-linked hyper-IgM syndrome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Immunological reconstitution by allogeneic bone marrow transplantation in a child with the X-linked hyper-IgM syndrome'. Together they form a unique fingerprint.

Cite this